Evaluating the Effectiveness and Acceptability of a GPT-4o and RAG-Based Voice Chatbot for Depression Screening Using PHQ-9
GPT4-RAG-PHQ
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to assess the feasibility and acceptability of a voice-based chatbot, powered by GPT-4o and Retrieval-Augmented Generation (RAG), for conducting depression screening using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a validated self-report instrument widely used to screen, diagnose, and monitor the severity of depression. It consists of nine questions that correspond to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for major depressive disorder. Respondents rate the frequency of symptoms experienced over the past two weeks on a scale from 0 ("not at all") to 3 ("nearly every day"). The total score (ranging from 0 to 27) indicates the severity of depressive symptoms, categorized into minimal, mild, moderate, moderately severe, or severe depression. The PHQ-9 is also used to assess functional impairment and guide treatment decisions in clinical and research settings. The voice-based chatbot integrates GPT-4o, with RAG to enhance its ability to provide informed and contextualized responses during interactions. GPT-4o serves as the conversational engine, capable of generating human-like, empathetic, and contextually appropriate dialogue. RAG, on the other hand, enables the chatbot to retrieve and incorporate external, up-to-date knowledge from a curated database or knowledge repository, ensuring the accuracy and reliability of its responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 30, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedJanuary 30, 2025
January 1, 2025
2 months
January 24, 2025
January 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility and Acceptability of the GPT-4o and RAG Voice Chatbot
Participants' perceptions of the chatbot's feasibility, acceptability, and effectiveness are assessed through semi-structured interviews conducted after the interaction session. These interviews explore themes such as the chatbot's empathy, usability, and the overall user experience.
Interviews are conducted immediately following the chatbot interaction.
Secondary Outcomes (1)
Accuracy of PHQ-9 Scoring by the Chatbot
Measured immediately after the interaction session, once the chatbot has generated PHQ-9 scores
Interventions
This study involves the use of a voice-based chatbot powered by GPT-4o and Retrieval-Augmented Generation (RAG) to conduct depression screening using the Patient Health Questionnaire-9 (PHQ-9). The chatbot aims to evaluate the feasibility and acceptability of using AI-powered conversational tools for mental health screening. Participants interact with the chatbot in a single session, answering PHQ-9 questions and receiving responses generated using GPT-4o and RAG technologies.
Eligibility Criteria
The study population consists of healthy individuals aged 18 to 65 years who do not have severe mental illnesses. We welcome participants who have an interest in artificial intelligence technologies. Recruitment will be conducted both online and offline. Participants will engage with a sophisticated AI chatbot designed to simulate a consultation with a mental health professional. This interaction enables them to complete a psychometric evaluation, such as the PHQ-9 test, in a structured yet conversational manner. Unlike conventional online versions of the PHQ-9 test, the chatbot offers enhanced interactivity. For individuals who may experience difficulties in articulating or summarizing their responses, the chatbot provides clarifications and assistance using a comprehensive language model. After the assessment, participants will receive an interpretation of their test results along with tailored advice, delivered in accordance with established mental health guidelines.
You may qualify if:
- Adults aged 18-65 years.
- Fluent in English.
- Access to a device capable of voice interaction and stable internet connection.
- Willing to participate in chatbot interaction and a follow-up interview.
You may not qualify if:
- Current severe psychiatric diagnoses (e.g., psychosis, bipolar disorder).
- Participants undergoing active treatment for depression with a psychiatrist.
- Discomfort with voice-based technology or inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCL Institute of Health Informatics
London, NW1 2DA, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kezhi Li
University College, London
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2025
First Posted
January 30, 2025
Study Start
February 1, 2025
Primary Completion
March 31, 2025
Study Completion
May 31, 2025
Last Updated
January 30, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to ensure participant confidentiality and comply with ethical guidelines related to mental health research. Additionally, participants did not provide explicit consent for data sharing with external researchers.